Gibson Christopher 的 Form 4 申報
Recursion Pharmaceuticals, Inc.（RXRX），2023/3/10 申報
- 申報編號
- 0001209191-23-017918
- 申報時間
- 2023/3/10
- 交易日
- 2023/3/8-3/9
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 10 筆非衍生性交易、4 筆衍生性交易。公開市場賣出合計 $89.3 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gibson ChristopherCIK 0001856369 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/3/8 | Class A Common Stock | M行使選擇權取得 | +93,750 | $2.48 | +$232,500 | 1,034,677 | 直接 | |
| 2023/3/8 | Class A Common Stock | S賣出處分 | −70,890 | $8.10F2 | −$574,209 | 963,787 | 直接 | |
| 2023/3/8 | Class A Common Stock | G贈與處分 | −10,000 | $0.00 | $0 | 953,787 | 直接 | |
| 2023/3/8 | Class A Common Stock | C轉換取得 | +4,000 | $0.00 | $0 | 4,000 | 間接 | |
| 2023/3/8 | Class A Common Stock | S賣出處分 | −4,000 | $8.09F5 | −$32,360 | 0 | 間接 | |
| 2023/3/8 | Class A Common Stock | C轉換取得 | +20,000 | $0.00 | $0 | 20,000 | 間接 | |
| 2023/3/8 | Class A Common Stock | S賣出處分 | −20,000 | $8.10F7 | −$162,000 | 0 | 間接 | |
| 2023/3/8 | Class A Common Stock | C轉換取得 | +1,000 | $0.00 | $0 | 1,000 | 間接 | |
| 2023/3/8 | Class A Common Stock | S賣出處分 | −1,000 | $8.09F9 | −$8,090 | 0 | 間接 | |
| 2023/3/9 | Class A Common Stock | S賣出處分 | −15,000 | $7.77F10 | −$116,550 | 938,787 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/3/8 | Class A Common Stock | M行使選擇權處分 | −93,750 | $0.00 | $0 | 687,500 | 直接 | |
| 2023/3/8 | Class A Common Stock | C轉換處分 | −4,000 | $0.00 | $0 | 535,000 | 間接 | |
| 2023/3/8 | Class A Common Stock | C轉換處分 | −20,000 | $0.00 | $0 | 508,000 | 間接 | |
| 2023/3/8 | Class A Common Stock | C轉換處分 | −1,000 | $0.00 | $0 | 123,875 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $7.98 to $8.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $8.02 to $8.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
This transaction was executed in multiple trades at prices ranging from $7.98 to $8.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
This transaction was executed in multiple trades at prices ranging from $8.03 to $8.28. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F10
This transaction was executed in multiple trades at prices ranging from $7.46 to $8.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。